rs133376

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The ENST00000898674.1(NAGA):​c.-70+183G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.37 in 166,156 control chromosomes in the GnomAD database, including 13,464 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 11709 hom., cov: 34)
Exomes 𝑓: 0.49 ( 1755 hom. )

Consequence

NAGA
ENST00000898674.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.190

Publications

20 publications found
Variant links:
Genes affected
NAGA (HGNC:7631): (alpha-N-acetylgalactosaminidase) NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease). [provided by RefSeq, Jul 2008]
NAGA Gene-Disease associations (from GenCC):
  • alpha-N-acetylgalactosaminidase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • alpha-N-acetylgalactosaminidase deficiency type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • alpha-N-acetylgalactosaminidase deficiency type 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • alpha-N-acetylgalactosaminidase deficiency type 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 22-42070901-C-T is Benign according to our data. Variant chr22-42070901-C-T is described in ClinVar as Benign. ClinVar VariationId is 684292.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.48 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000898674.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGA
NM_000262.3
MANE Select
c.-604G>A
upstream_gene
N/ANP_000253.1P17050
NAGA
NM_001362848.1
c.-215G>A
upstream_gene
N/ANP_001349777.1P17050
NAGA
NM_001362850.1
c.-208G>A
upstream_gene
N/ANP_001349779.1P17050

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGA
ENST00000898674.1
c.-70+183G>A
intron
N/AENSP00000568733.1
NAGA
ENST00000958241.1
c.-77+183G>A
intron
N/AENSP00000628300.1
NAGA
ENST00000396398.8
TSL:1 MANE Select
c.-604G>A
upstream_gene
N/AENSP00000379680.3P17050

Frequencies

GnomAD3 genomes
AF:
0.359
AC:
54592
AN:
152072
Hom.:
11697
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.117
Gnomad AMI
AF:
0.489
Gnomad AMR
AF:
0.489
Gnomad ASJ
AF:
0.361
Gnomad EAS
AF:
0.324
Gnomad SAS
AF:
0.452
Gnomad FIN
AF:
0.503
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.448
Gnomad OTH
AF:
0.383
GnomAD4 exome
AF:
0.491
AC:
6860
AN:
13966
Hom.:
1755
AF XY:
0.492
AC XY:
3740
AN XY:
7602
show subpopulations
African (AFR)
AF:
0.169
AC:
41
AN:
242
American (AMR)
AF:
0.541
AC:
1363
AN:
2518
Ashkenazi Jewish (ASJ)
AF:
0.380
AC:
38
AN:
100
East Asian (EAS)
AF:
0.381
AC:
282
AN:
740
South Asian (SAS)
AF:
0.498
AC:
1315
AN:
2640
European-Finnish (FIN)
AF:
0.590
AC:
131
AN:
222
Middle Eastern (MID)
AF:
0.536
AC:
15
AN:
28
European-Non Finnish (NFE)
AF:
0.492
AC:
3404
AN:
6918
Other (OTH)
AF:
0.486
AC:
271
AN:
558
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
165
329
494
658
823
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.359
AC:
54610
AN:
152190
Hom.:
11709
Cov.:
34
AF XY:
0.365
AC XY:
27183
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.116
AC:
4838
AN:
41544
American (AMR)
AF:
0.489
AC:
7479
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1255
AN:
3472
East Asian (EAS)
AF:
0.325
AC:
1677
AN:
5160
South Asian (SAS)
AF:
0.453
AC:
2184
AN:
4824
European-Finnish (FIN)
AF:
0.503
AC:
5324
AN:
10586
Middle Eastern (MID)
AF:
0.342
AC:
100
AN:
292
European-Non Finnish (NFE)
AF:
0.448
AC:
30483
AN:
67984
Other (OTH)
AF:
0.389
AC:
824
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1664
3329
4993
6658
8322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.395
Hom.:
3161
Bravo
AF:
0.350
Asia WGS
AF:
0.414
AC:
1438
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
15
DANN
Benign
0.92
PhyloP100
-0.19
PromoterAI
-0.25
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs133376; hg19: chr22-42466905; API